<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Infect</journal-id><journal-id journal-id-type="iso-abbrev">J Infect</journal-id><journal-title-group><journal-title>The Journal of Infection</journal-title></journal-title-group><issn pub-type="ppub">0163-4453</issn><issn pub-type="epub">1532-2742</issn><publisher><publisher-name>The British Infection Association. Published by Elsevier Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">35421520</article-id><article-id pub-id-type="pmc">PMC9001010</article-id><article-id pub-id-type="pii">S0163-4453(22)00201-8</article-id><article-id pub-id-type="doi">10.1016/j.jinf.2022.04.019</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letter to the Editor</subject></subj-group></article-categories><title-group><article-title>Inhibition of endocytic recycling of ACE2 by SARS-CoV-2 S protein partially explains multiple COVID-19 related diseases caused by ACE2 reduction</article-title></title-group><contrib-group><contrib contrib-type="author" id="au0001"><name><surname>Ren</surname><given-names>Yongwen</given-names></name><xref rid="aff0001" ref-type="aff">a</xref><xref rid="aff0002" ref-type="aff">b</xref><xref rid="aff0003" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="au0002"><name><surname>Lv</surname><given-names>Lu</given-names></name><xref rid="aff0002" ref-type="aff">b</xref><xref rid="aff0003" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="au0003"><name><surname>Li</surname><given-names>Peng</given-names></name><xref rid="aff0002" ref-type="aff">b</xref><xref rid="aff0003" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="au0004"><name><surname>Zhang</surname><given-names>Leiliang</given-names></name><xref rid="aff0001" ref-type="aff">a</xref><xref rid="aff0002" ref-type="aff">b</xref><xref rid="aff0003" ref-type="aff">c</xref><xref rid="cor0001" ref-type="corresp">&#x0204e;</xref></contrib><aff id="aff0001"><label>a</label>Department of Clinical Laboratory Medicine, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China</aff><aff id="aff0002"><label>b</label>Department of Pathogen Biology, School of Basic Medical Sciences, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China</aff><aff id="aff0003"><label>c</label>Medical Science and Technology Innovation Center, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China</aff></contrib-group><author-notes><corresp id="cor0001"><label>&#x0204e;</label>Corresponding author at: Department of Clinical Laboratory Medicine, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China.</corresp></author-notes><pub-date pub-type="pmc-release"><day>12</day><month>4</month><year>2022</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="ppub"><month>7</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>12</day><month>4</month><year>2022</year></pub-date><volume>85</volume><issue>1</issue><fpage>e21</fpage><lpage>e23</lpage><history><date date-type="accepted"><day>6</day><month>4</month><year>2022</year></date></history><permissions><copyright-statement>&#x000a9; 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder/><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions></article-meta></front><body><p content-type="salutation"><italic>Dear editor</italic></p><p id="para0006">In this Journal, Li and colleagues described the comparative biology of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor ACE2 and provided some explanation of the host range.<xref rid="bib0001" ref-type="bibr"><sup>1</sup></xref> Reduction of ACE2 protein level leads to a variety of diseases, such as lung injury, hypertension and abnormal coagulation.<xref rid="bib0002" ref-type="bibr"><sup>2</sup></xref> It has been reported that the protein level of ACE2 decreases during SARS-CoV-2 infection.<xref rid="bib0003" ref-type="bibr"><sup>3</sup></xref> To explain this phenomenon, we hypothesize that SARS-CoV-2 disrupts the homeostasis of ACE2 by interfering its trafficking to plasma membrane.</p><p id="para0007">Sorting nexin 27 (SNX27) mediates endocytic recycling of cargo proteins containing C-terminal PSD95/Dlg1/ZO-1 (PDZ)-binding sequences from endosomes to the plasma membrane, preventing their lysosomal degradation.<xref rid="bib0004" ref-type="bibr"><sup>4</sup></xref> Human ACE2 (hACE2) contains a SNX27-PDZ domain binding motif DVQTSF in its C terminus (<xref rid="fig0001" ref-type="fig">Fig.&#x000a0;1</xref>
A), indicating that ACE2 may interact with SNX27. Indeed, GST pulldown experiments demonstrated that hACE2 but not hACE2T803A/F805A associated with both PDZ domain of SNX27 and full length SNX27 (<xref rid="fig0001" ref-type="fig">Fig.&#x000a0;1</xref>B). Immunofluorescence staining showed that the surface signal of ACE2T803A/F805A was weaker than that of wild type ACE2, suggesting that binding to SNX27 was crucial for the plasma membrane targeting of ACE2 (<xref rid="fig0001" ref-type="fig">Fig.&#x000a0;1</xref>C). Moreover, silencing SNX27 by siRNA reduced the surface level of ACE2, confirming that ACE2 was delivered to the cell surface through SNX27 (<xref rid="fig0001" ref-type="fig">Fig.&#x000a0;1</xref>D). Taken together, those results demonstrated that endocytic recycling of ACE2 was mediated by SNX27.<fig id="fig0001"><label>Fig. 1</label><caption><p>Endocytic recycling of ACE2 is mediated by SNX27. (A) Human ACE2 contains a SNX27 PDZ binding motif in the C-terminus. (B) Both SNX27 and its PDZ domain associate with ACE2 but not T803A/F805A mutant of ACE2 in GST pulldown experiments. Lysates from 293T cells transfected with the constructs expressing HA-tagged wild type hACE2 and T803A/F805A mutant of hACE2 were pulled down by GST&#x02013;SNX27, GST-SNX27 PDZ or GST. Input represents 2% of total cell lysates. (C) Surface level of T803A/F805A mutant of ACE2 is weaker than that of wild type ACE2. HeLa cells transfected with the constructs expressing HA-tagged wild type hACE2 and T803A/F805A mutant of hACE2 were stained with HA antibody. ACE2-HA and T803A/F805A mutant of ACE2-HA are in red. Nucleus stained with DAPI is in Blue. Scale bar: 10&#x000a0;&#x003bc;M. Relative ACE2 intensity was normalized by quantifying at least 20 cells through Image J. ****, <italic>p</italic> value &#x0003c; 0.0001. (D) Silencing SNX27 by siRNA reduces surface level of ACE2. HeLa cells treated with siRNA against SNX27 for 3 days and then transfected with the construct expressing HA-tagged wild type hACE2 were stained with HA antibody. ACE2-HA is in red. Nucleus stained with DAPI is in Blue. Scale bar: 10&#x000a0;&#x003bc;M. Relative ACE2 intensity was normalized by quantifying at least 20 cells through Image J. ****, <italic>p</italic> value &#x0003c; 0.0001. HeLa cells were treated with siRNA against SNX27 for 3 days and then blotted with antibodies against SNX27 or &#x003b2;-actin.</p></caption><alt-text id="alt0001">Fig 1</alt-text><graphic xlink:href="gr1_lrg"/></fig></p><p id="para0008">SARS-CoV-2 spike (S) protein also contains a potential SNX27 binding motif MTSC in the cytoplasmic tail (<xref rid="fig0002" ref-type="fig">Fig.&#x000a0;2</xref>
A), indicating that S may associate with SNX27. GST pulldown experiments confirmed that S interacted with both PDZ domain of SNX27 and full length SNX27 (<xref rid="fig0002" ref-type="fig">Fig.&#x000a0;2</xref>B). Further GST pulldown experiments showed that S but not T1238A mutant of S associated with both PDZ domain of SNX27 and full length SNX27, suggesting T1238 in S was critical for its SNX27 association (<xref rid="fig0002" ref-type="fig">Fig.&#x000a0;2</xref>C). Since both S and ACE2 interacted with PDZ domain of SNX27, we hypothesized that SARS-CoV-2 S competed with ACE2 for associating with SNX27. To test this hypothesis, we performed GST pulldown experiments and found that overexpression of GFP-S but not GFP reduced the binding ability of ACE2 to PDZ domain of SNX27 or full length SNX27 (<xref rid="fig0002" ref-type="fig">Fig.&#x000a0;2</xref>D and E). However, when overexpressing SARS-CoV-2 S-T1238A in which the SNX27 binding affinity was abolished, the association of ACE2 with SNX27 PDZ or SNX27 was recovered, suggesting that S blocked SNX27-ACE2 interaction through its association with SNX27 (<xref rid="fig0002" ref-type="fig">Fig.&#x000a0;2</xref>F and G). Compared with GFP, GFP-S but not GSP-S-T1238A mutant reduced the surface level of ACE2, which suggested that S suppressed the endocytic recycling of ACE2 through SNX27 (<xref rid="fig0002" ref-type="fig">Fig.&#x000a0;2</xref>H). Taken together, SARS-CoV-2 S inhibited the endocytic recycling of ACE2 mediated by SNX27.<fig id="fig0002"><label>Fig. 2</label><caption><p>SARS-CoV-2 S protein reduces the surface level of ACE2 by associating with SNX27. (A) SARS-CoV-2 S protein contains a SNX27 binding motif in the C-terminus. (B) Both SNX27 and its PDZ domain associate with SARS-CoV-2 S. Lysates from 293T cells transfected with the constructs expressing GFP-tagged SARS-CoV-2 S were pulled down by GST&#x02013;SNX27, GST-SNX27 PDZ or GST. Input represents 2% of total cell lysates. (C) Both SNX27 and its PDZ domain associate with SARS-CoV-2 S but not T1238A mutant of SARS-CoV-2 S in GST pulldown experiments. Lysates from 293T cells transfected with the constructs expressing GFP-tagged SARS-CoV-2 S or T1238A mutant of SARS-CoV-2 S were pulled down by GST&#x02013;SNX27 or GST-SNX27 PDZ. Input represents 2% of total cell lysates. (D) SARS-CoV-2 S inhibits the interaction between ACE2 and SNX27 PDZ domain in GST pulldown experiments. Lysates from 293T cells transfected with the constructs expressing HA-tagged ACE2 with GFP-tagged SARS-CoV-2 S or GFP were pulled down by GST&#x02013;SNX27 PDZ or GST. Input represents 2% of total cell lysates. (E) SARS-CoV-2 S suppresses the interaction between ACE2 and SNX27 in GST pulldown experiments. Lysates from 293T cells transfected with the constructs expressing HA-tagged ACE2 with GFP-tagged SARS-CoV-2 S or GFP were pulled down by GST&#x02013;SNX27 or GST. Input represents 2% of total cell lysates. (F) SARS-CoV-2 S but not T1238A mutant of SARS-CoV-2 S inhibits the interaction between ACE2 and SNX27 PDZ domain in GST pulldown experiments. Lysates from 293T cells transfected with the constructs expressing HA-tagged ACE2 with GFP-tagged SARS-CoV-2 S, T1238A mutant of SARS-CoV-2 S, or GFP were pulled down by GST&#x02013;SNX27 PDZ or GST. Input represents 2% of total cell lysates. (G) SARS-CoV-2 S but not T1238A mutant of SARS-CoV-2 S suppresses the interaction between ACE2 and SNX27 in GST pulldown experiments. Lysates from 293T cells transfected with the constructs expressing HA-tagged ACE2 with GFP-tagged SARS-CoV-2 S, T1238A mutant of SARS-CoV-2 S, or GFP were pulled down by GST&#x02013;SNX27 or GST. Input represents 2% of total cell lysates. (H) Compared with GFP, GFP-S but not GSP-S-T1238A mutant reduces the surface level of ACE2. HeLa cells transfected with the constructs expressing HA-tagged ACE2 with GFP-tagged SARS-CoV-2 S, T1238A mutant of SARS-CoV-2 S, or GFP were stained with HA antibody. ACE2-HA is in red. SARS-CoV-2 S, T1238A mutant of SARS-CoV-2 S, and GFP are in green. Nucleus stained with DAPI is in Blue. Scale bar: 10&#x000a0;&#x003bc;M. Relative ACE2 intensity was normalized by quantifying at least 20 cells through Image J. ***, <italic>p</italic> value &#x0003c; 0.001; ****, <italic>p</italic> value &#x0003c; 0.0001. (I) Model of how SARS-CoV-2 S blocks ACE2 transport mediated by SNX27. Endocytic recycling of ACE2 is mediated by SNX27. SARS-CoV-2 S could inhibit plasma membrane targeting of ACE2 by suppressing the association of SNX27 and ACE2, leading to the reduction of ACE2.</p></caption><alt-text id="alt0002">Fig 2</alt-text><graphic xlink:href="gr2_lrg"/></fig></p><p id="para0009">Consistent with our study, recent studies found that ACE2 surface localization was mediated by SNX27 and SARS-CoV-2 S associated with SNX27.<xref rid="bib0005" ref-type="bibr">5</xref>, <xref rid="bib0006" ref-type="bibr">6</xref>, <xref rid="bib0007" ref-type="bibr">7</xref>, <xref rid="bib0008" ref-type="bibr">8</xref> However, those studies did not explore the role for SARS-CoV-2 S in the endocytic recycling of ACE2. Our finding advanced our understanding of many phenomena caused by ACE2-deficiency. In the last two years, long COVID concept has been gradually accepted.<xref rid="bib0009" ref-type="bibr"><sup>9</sup></xref> Upon SARS-CoV-2 infection, endocytic recycling of ACE2 mediated by SNX27 could be suppressed by SARS-CoV-2 S and surface level of ACE2 would be decreased (<xref rid="fig0002" ref-type="fig">Fig.&#x000a0;2</xref>I), which could lead to many long COVID diseases due to the deficiency of ACE2. Meanwhile, some side effects of S-based SARS-CoV-2 vaccine may due to the reduction of ACE2 recycling by S. For instance, myocarditis and pericarditis appeared after administration of BNT162b2 from BioNTech and mRNA-1273 from Moderna.<xref rid="bib0010" ref-type="bibr"><sup>10</sup></xref> It is possible that ACE2-dificiency by SARS-CoV-2 S causes those side effects. Because T1238A mutant of SARS-CoV-2 S no longer suppresses endocytic recycling of ACE2, this mutant could be a better design for mRNA vaccine against SARS-CoV-2.</p><p id="para0010">In this study, we revealed the mechanism how SARS-CoV-2 S protein lowered the surface level of ACE2. SARS-CoV-2 S decreased the surface level of ACE2 by inhibiting endocytic recycling of ACE2 mediated by SNX27. ACE2 reduction by SARS-CoV-2 is considered as a critical driver for COVID-19 pathology, which could cause multiple diseases, such as lung injury, hypertension and abnormal coagulation. Our study provided new ideas for understanding some symptoms of SARS-CoV-2 infection, which could help the treatment of various diseases caused by SARS-CoV-2.</p><sec sec-type="COI-statement"><title>Declaration of Competing Interest</title><p id="para0011">The authors declare that there are no conflicts of interest.</p></sec></body><back><ref-list id="cebibl1"><title>References</title><ref id="bib0001"><label>1</label><element-citation publication-type="journal" id="sbref0001"><person-group person-group-type="author"><name><surname>Li</surname><given-names>R.</given-names></name><name><surname>Qiao</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name></person-group><article-title>Analysis of angiotensin-converting enzyme 2 (ACE2) from different species sheds some light on cross-species receptor usage of a novel coronavirus 2019-nCoV</article-title><source>J Infect</source><volume>80</volume><year>2020</year><fpage>469</fpage><lpage>496</lpage></element-citation></ref><ref id="bib0002"><label>2</label><element-citation publication-type="journal" id="sbref0002"><person-group person-group-type="author"><name><surname>Angeli</surname><given-names>F.</given-names></name><name><surname>Zappa</surname><given-names>M.</given-names></name><name><surname>Reboldi</surname><given-names>G.</given-names></name><name><surname>Trapasso</surname><given-names>M.</given-names></name><name><surname>Cavallini</surname><given-names>C.</given-names></name><name><surname>Spanevello</surname><given-names>A.</given-names></name><name><surname>Verdecchia</surname><given-names>P.</given-names></name></person-group><article-title>The pivotal link between ACE2 deficiency and SARS-CoV-2 infection: one year later</article-title><source>Eur J Intern Med</source><volume>93</volume><year>2021</year><fpage>28</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">34588140</pub-id></element-citation></ref><ref id="bib0003"><label>3</label><element-citation publication-type="journal" id="sbref0003"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Schiavon</surname><given-names>C.R.</given-names></name><name><surname>He</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Shen</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Yin</surname><given-names>Q.</given-names></name><name><surname>Cho</surname><given-names>Y.</given-names></name><name><surname>Andrade</surname><given-names>L.</given-names></name><name><surname>Shadel</surname><given-names>G.S.</given-names></name><name><surname>Hepokoski</surname><given-names>M.</given-names></name><name><surname>Lei</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Yuan</surname><given-names>J.X.</given-names></name><name><surname>Malhotra</surname><given-names>A.</given-names></name><name><surname>Manor</surname><given-names>U.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Yuan</surname><given-names>Z.Y.</given-names></name><name><surname>Shyy</surname><given-names>J.Y.</given-names></name></person-group><article-title>SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE2</article-title><source>Circ Res</source><volume>128</volume><year>2021</year><fpage>1323</fpage><lpage>1326</lpage><pub-id pub-id-type="pmid">33784827</pub-id></element-citation></ref><ref id="bib0004"><label>4</label><element-citation publication-type="journal" id="sbref0004"><person-group person-group-type="author"><name><surname>Steinberg</surname><given-names>F.</given-names></name><name><surname>Gallon</surname><given-names>M.</given-names></name><name><surname>Winfield</surname><given-names>M.</given-names></name><name><surname>Thomas</surname><given-names>E.C.</given-names></name><name><surname>Bell</surname><given-names>A.J.</given-names></name><name><surname>Heesom</surname><given-names>K.J.</given-names></name><name><surname>Tavar&#x000e9;</surname><given-names>J.M.</given-names></name><name><surname>Cullen</surname><given-names>P.J.</given-names></name></person-group><article-title>A global analysis of SNX27-retromer assembly and cargo specificity reveals a function in glucose and metal ion transport</article-title><source>Nat Cell Biol</source><volume>15</volume><year>2013</year><fpage>461</fpage><lpage>471</lpage><pub-id pub-id-type="pmid">23563491</pub-id></element-citation></ref><ref id="bib0005"><label>5</label><element-citation publication-type="journal" id="sbref0005"><person-group person-group-type="author"><name><surname>Kliche</surname><given-names>J.</given-names></name><name><surname>Kuss</surname><given-names>H.</given-names></name><name><surname>Ali</surname><given-names>M.</given-names></name><name><surname>Ivarsson</surname><given-names>Y.</given-names></name></person-group><article-title>Cytoplasmic short linear motifs in ACE2 and integrin &#x003b2;(3) link SARS-CoV-2 host cell receptors to mediators of endocytosis and autophagy</article-title><source>Sci Signal</source><volume>14</volume><year>2021</year><fpage>eabf1117</fpage><pub-id pub-id-type="pmid">33436498</pub-id></element-citation></ref><ref id="bib0006"><label>6</label><element-citation publication-type="journal" id="sbref0006"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>B.</given-names></name><name><surname>Jia</surname><given-names>Y.</given-names></name><name><surname>Meng</surname><given-names>Y.</given-names></name><name><surname>Xue</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Cui</surname><given-names>K.</given-names></name><name><surname>Shang</surname><given-names>L.</given-names></name><name><surname>Cheng</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Hou</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Yan</surname><given-names>H.</given-names></name><name><surname>Duan</surname><given-names>L.</given-names></name><name><surname>Tong</surname><given-names>Z.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Gao</surname><given-names>S.</given-names></name><name><surname>Zhuo</surname><given-names>S.</given-names></name><name><surname>Huang</surname><given-names>W.</given-names></name><name><surname>Gao</surname><given-names>G.F.</given-names></name><name><surname>Qi</surname><given-names>J.</given-names></name><name><surname>Shang</surname><given-names>G.</given-names></name></person-group><article-title>SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry</article-title><source>Proc Natl Acad Sci U S A</source><volume>119</volume><year>2022</year><object-id pub-id-type="publisher-id">e2117576119</object-id></element-citation></ref><ref id="bib0007"><label>7</label><element-citation publication-type="journal" id="sbref0007"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Gefter</surname><given-names>J.</given-names></name><name><surname>Sneddon</surname><given-names>W.B.</given-names></name><name><surname>Mamonova</surname><given-names>T.</given-names></name><name><surname>Friedman</surname><given-names>P.A.</given-names></name></person-group><article-title>ACE2 interaction with cytoplasmic PDZ protein enhances SARS-CoV-2 invasion</article-title><source>iScience</source><volume>24</volume><year>2021</year><object-id pub-id-type="publisher-id">102770</object-id></element-citation></ref><ref id="bib0008"><label>8</label><element-citation publication-type="journal" id="sbref0008"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Zhong</surname><given-names>K.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Yong</surname><given-names>X.</given-names></name><name><surname>Tong</surname><given-names>A.</given-names></name><name><surname>Jia</surname><given-names>D.</given-names></name></person-group><article-title>SARS-CoV-2 spike protein harnesses SNX27-mediated endocytic recycling pathway</article-title><source>MedComm (2020)</source><volume>2</volume><year>2021</year><fpage>798</fpage><lpage>809</lpage><pub-id pub-id-type="pmid">34909756</pub-id></element-citation></ref><ref id="bib0009"><label>9</label><element-citation publication-type="journal" id="sbref0009"><person-group person-group-type="author"><name><surname>Alwan</surname><given-names>N.A.</given-names></name></person-group><article-title>The road to addressing long covid</article-title><source>Science</source><volume>373</volume><year>2021</year><fpage>491</fpage><lpage>493</lpage><pub-id pub-id-type="pmid">34326224</pub-id></element-citation></ref><ref id="bib0010"><label>10</label><element-citation publication-type="journal" id="sbref0010"><person-group person-group-type="author"><name><surname>Patone</surname><given-names>M.</given-names></name><name><surname>Mei</surname><given-names>X.W.</given-names></name><name><surname>Handunnetthi</surname><given-names>L.</given-names></name><name><surname>Dixon</surname><given-names>S.</given-names></name><name><surname>Zaccardi</surname><given-names>F.</given-names></name><name><surname>Shankar-Hari</surname><given-names>M.</given-names></name><name><surname>Watkinson</surname><given-names>P.</given-names></name><name><surname>Khunti</surname><given-names>K.</given-names></name><name><surname>Harnden</surname><given-names>A.</given-names></name><name><surname>Coupland</surname><given-names>C.A.C.</given-names></name><name><surname>Channon</surname><given-names>K.M.</given-names></name><name><surname>Mills</surname><given-names>N.L.</given-names></name><name><surname>Sheikh</surname><given-names>A.</given-names></name><name><surname>Hippisley-Cox</surname><given-names>J.</given-names></name></person-group><article-title>Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection</article-title><source>Nat Med</source><volume>28</volume><year>2022</year><fpage>410</fpage><lpage>422</lpage><pub-id pub-id-type="pmid">34907393</pub-id></element-citation></ref></ref-list><ack id="ack0001"><title>Acknowledgments</title><p id="para0012">This work was supported by grants from <funding-source id="gs0001"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source> [82072270 and 81871663], and Academic promotion program of <funding-source id="gs0002"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100015507</institution-id><institution>Shandong First Medical University</institution></institution-wrap></funding-source> [2019LJ001].</p></ack></back></article>
